Actinic Keratosis Market Infographics
Actinic Keratosis Market

Actinic Keratosis (AK) referred to as solar keratosis is a rough, scaly patch development on the skin from years of intense UV rays sun exposure found often on the face, lips, ears, forearms, scalp, neck, and back of the hands


Some of the key symptoms of Actinic Keratosis include a rough, dry, or scaly patch of skin, a flat to slightly raised patch or bump on the top layer of skin, color variations, including pink, red or brown, itching, burning, bleeding or crusting, new patches or bumps on sun-exposed areas of the head, neck, hands, and forearms.  The major risk factors for Actinic Keratosis include having red or blond hair and blue or light-colored eyes, history of a lot of sun exposure or sunburn, tending to freckles or burn when exposed to sunlight, older than 40, living in a sunny place, work outdoors, and having a weakened immune system


Actinic Keratosis Epidemiology Insights Observed in 2020

The total prevalent cases of Actinic Keratosis in 7MM were observed to be 18,523,526.

The highest prevalent cases of Actinic Keratosis were in the US with 62% of the total prevalent cases. 

The prevalent population of Actinic Keratosis in Germany was found to be 1,822,426, while France and Spain had 1,372,165 and 813,743 cases respectively.

Japan had around 527,934 cases in 2020.


Actinic Keratosis Epidemiology Segmentation in the 7MM for the Study Period 2018-30

  • Total Prevalent Actinic Keratosis cases 
  • Subtype Specific Prevalent cases of Actinic Keratosis
  • Age-Specific Actinic Keratosis Prevalence


Actinic Keratosis Market Insight

The Actinic Keratosis Market Size in the 7MM was found to be USD 1.4 million in 2020.


Actinic Keratosis Market Drivers

  • Cost driver to patient healthcare spending
  • Improvement in disease management
  • Improvement in diagnosis
  • New treatment modalities


Actinic Keratosis Market Barriers

  • Risk associated
  • Socioeconomic burden
  • Patient education
  • Burden on healthcare


Actinic Keratosis Emerging Therapies

The emerging drugs in the Actinic Keratosis market are

  • VDA-1102
  • DFD-07
  • SR-T100 Gel
  • GDC695
  • PD P 506 A
  • AM-001

And several others.


Actinic Keratosis Market Prominent Players

The key companies in the Actinic Keratosis market are

  • Vidac Pharma
  • Promius Pharma
  • G&E Herbal Biotechnology
  • Gage Development Company
  • Photonamic GmbH & Co. KG
  • AmDerma Pharmaceuticals, LLC.

And several others.